1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-25-446
PAR-25-446National Institutes of HealthUG3

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Deadline
2026-10-20
47 days left
Award ceiling
$3,000,000
Awards
—
Posted
2025-09-10

Summary

The purpose of this Funding Opportunity (NOFO) is to solicit grant applications to support research on the discovery and development of interventions to prevent and/or treat substance use disorders (SUDs) and overdose, including medications and medical devices to treat co-morbid SUDs. […]

The rest of this announcement — free with an account

  • →The full announcement text, not the first two sentences
  • →All 3 review criteria reviewers score this against, extracted from this announcement
  • →Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
  • →What similar funded projects received, from 219,000 past awards
Create free accountSign in

No card required. Browsing and your first match are free.

substance-use

More from National Institutes of Health

See all →
RFA-RM-27-003 • National Institutes of Health

NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)

The NIH Director's Transformative Research Award supports collaborative investigative teams or individual scientists who propose unusually bold and innovative research projects, which, if successful, would have a major impact in a broad area of relevance to the NIH.

3 review criteria on file
amount not statedDue 2026-09-030 days left
PA-27-102 • National Institutes of Health

NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)

S. technology development and commercialization.

6 review criteria on file
amount not statedDue 2026-09-052 days left
PA-27-101 • National Institutes of Health

NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

S. technology development and commercialization.

7 review criteria on file
amount not statedDue 2026-09-052 days left
PA-27-100 • National Institutes of Health

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

S. technology development and commercialization.

6 review criteria on file
amount not statedDue 2026-09-052 days left

Also in substance-use

PAR-25-347 • National Institutes of Health

Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)

The goal of this notice of funding opportunity (NOFO) is to support doctoral candidates from a variety of academic disciplines for up to two years for the completion of the doctoral dissertation research project.gov) .

3 review criteria on file
amount not statedDue 2026-09-074 days left
PA-25-245 • National Institutes of Health

Alcohol Health Services Research (R01 Clinical Trial Optional)

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services.

3 review criteria on file
$500,000award ceilingDue 2026-09-074 days left
PA-25-163 • National Institutes of Health

Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research.

3 review criteria on file
$500,000award ceilingDue 2026-09-074 days left

Official announcement: https://grants.nih.gov/grants/guide/pa-files/PAR-25-446.htmlSource: nih_guide+grants_gov. Always confirm dates with the funder.